{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:26Z","timestamp":1767135146188,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009077.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000}}],"reference-count":123,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009077.pub3","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T08:13:41Z","timestamp":1467965621000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy"],"prefix":"10.1002","volume":"2016","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"first","affiliation":[{"name":"Iberoamerican Cochrane Network; Valencia Venezuela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joey SW","family":"Kwong","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Evidence-Based Medicine Center; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD009077.pub3-BIB0001|cit1","first-page":"90","article-title":"Effects of administration of short-term rosuvastatin in patients with heart failure due to Chagas disease etiology: A randomized, placebo-controlled trial","volume":"30","author":"Andrade","year":"2012","journal-title":"Cardiovascular Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ahj.2006.12.017","article-title":"A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy","volume":"153","author":"Botoni","year":"2007","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0004|cit3","unstructured":"Diniz RVZ Effect and tolerability of the carvedilol in chronic symptomatic Chagasic cardiomyopathy S\u00e3o Paulo, Brazil, Universidade Federal de S\u00e3o Paulo 2004"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0003|cit4","unstructured":"Diniz RVZ Viegas RFM Amori JML Pulz C Carvalho ACDC Almeida DR Arquivos Brasileiros de Cardiologia 2005 66 10.1590\/S0066-782X2005000100014"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijcard.2010.05.033","article-title":"Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure","volume":"151","author":"Bestetti","year":"2011","journal-title":"International Journal of Cardiology"},{"issue":"2-3","key":"10.1002\/14651858.CD009077.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0167-5273(02)00181-X","article-title":"Effects of metoprolol in chagasic patients with severe congestive heart failure","volume":"85","author":"D\u00e1vila","year":"2002","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD009077.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2008.01.001","article-title":"Beta-adrenergic blockers in chronic systolic heart failure secondary to Chagas' disease","volume":"128","author":"D\u00e1vila","year":"2008","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCHEARTFAILURE.107.744870","article-title":"Long-term prospective, randomized, controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients: the REMADHE trial","volume":"1","author":"Bocchi","year":"2008","journal-title":"Circulation. Heart Failure"},{"issue":"1","key":"10.1002\/14651858.CD009077.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCHEARTFAILURE.109.882035","article-title":"Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial","volume":"3","author":"Issa","year":"2010","journal-title":"Circulation. Heart Failure"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0010|cit10","unstructured":"Morillo CA A randomized double-blind placebo force-titration controlled study with bisoprolol in patients with chronic heart failure secondary to Chagas\u00b4 cardiomyopathy https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00323973 (accessed 29 January 2016)"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ijcard.2013.01.262","article-title":"Chagas' cardiomyopathy: the economic burden of an expensive and neglected disease","volume":"168","author":"Abuhab","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1157\/13116195","article-title":"Predicting heart failure and mortality in chronic Chagas' heart disease. A novel disorder in Spain","volume":"61","author":"Acquatella","year":"2008","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10741-006-9482-z","article-title":"Pharmacological treatment of chronic heart failure","volume":"11","author":"Adorisio","year":"2006","journal-title":"Heart Failure Reviews"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ"},{"issue":"2 Suppl 3","key":"10.1002\/14651858.CD009077.pub3-BIB0015|cit15","first-page":"1","article-title":"I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy","volume":"97","author":"Andrade","year":"2011","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"15","key":"10.1002\/14651858.CD009077.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2012.466","article-title":"Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective","volume":"307","author":"Basch","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00129784-200606020-00002","article-title":"Mechanisms, manifestations, and management of digoxin toxicity in the modern era","volume":"6","author":"Bauman","year":"2006","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"5","key":"10.1002\/14651858.CD009077.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1086\/605091","article-title":"An estimate of the burden of Chagas disease in the United States","volume":"49","author":"Bern","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.ijcard.2013.04.015","article-title":"Prognosis of patients with chronic systolic heart failure: Chagas disease versus systemic arterial hypertension","volume":"168","author":"Bestetti","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijcard.2014.04.142","article-title":"Mode of death in chronic systolic heart failure: Chagas cardiomyopathy versus systemic arterial hypertension","volume":"174","author":"Bestetti","year":"2014","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/AC.69.2.3017306","article-title":"Chagas disease: don't forget it in Latin American patients with heart block!","volume":"69","author":"Bimbi","year":"2014","journal-title":"Acta Cardiologica"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pcad.2009.11.008","article-title":"Chagas cardiomyopathy - where do we stand after a hundred years?","volume":"52","author":"Biolo","year":"2010","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD009077.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/156652408785748004","article-title":"Chagas heart disease pathogenesis: one mechanism or many?","volume":"8","author":"Bonney","year":"2008","journal-title":"Current Molecular Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009077.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1398-9995.2010.02530.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations","volume":"66","author":"Brozek","year":"2011","journal-title":"Allergy"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0026|cit26","first-page":"[Epub ahead of","article-title":"Advances in Chagas disease drug development: 2009-2010","volume":"Sep 30","author":"Buckner","year":"2010","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD009077.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"e1707","DOI":"10.1371\/journal.pntd.0001707","article-title":"Geographical distribution of Trypanosoma cruzi genotypes in Venezuela","volume":"6","author":"Carrasco","year":"2012","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: Defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4419-5638-5_7","article-title":"Ecological niche modelling as a tool for understanding distributions and interactions of vectors, hosts, and etiologic agents of Chagas disease","volume":"710","author":"Costa","year":"2012","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1-2","key":"10.1002\/14651858.CD009077.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.actatropica.2010.03.008","article-title":"Chagas disease: 100 years after its discovery. A systemic review","volume":"115","author":"Coura","year":"2010","journal-title":"Acta Tropica"},{"issue":"1-2","key":"10.1002\/14651858.CD009077.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mbs.2012.03.005","article-title":"Control measures for Chagas disease","volume":"237","author":"Cruz-Pacheco","year":"2012","journal-title":"Mathematical Biosciences"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0033|cit33","first-page":"11","article-title":"Chagas disease cardiomyopathy: Immunopathology and genetics","volume":"Epub Aug 19","author":"Cunha-Neto","year":"2014","journal-title":"Mediators of Inflammation"},{"issue":"7","key":"10.1002\/14651858.CD009077.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.01742-09","article-title":"Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi","volume":"54","author":"Diniz Lde","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD009077.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2459\/JCM.0b013e32830eb6fe","article-title":"Chagas' heart disease in Europe: an emergent disease?","volume":"9","author":"Dobarro","year":"2008","journal-title":"Journal of Cardiovascular Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/QCO.0b013e3282f88b80","article-title":"Current concepts in immunoregulation and pathology of human Chagas disease","volume":"21","author":"Dutra","year":"2008","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD009077.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0020-7519(01)00311-3","article-title":"Pathogenesis of chronic Chagas heart disease: parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation","volume":"32","author":"D\u00e1vila","year":"2002","journal-title":"International Journal for Parasitology"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2003.06.015","article-title":"A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease","volume":"96","author":"D\u00e1vila","year":"2004","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijcard.2004.11.006","article-title":"Vagal dysfunction and the pathogenesis of chronic Chagas disease","volume":"100","author":"D\u00e1vila","year":"2005","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4269\/ajtmh.2003.68.242","article-title":"Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease","volume":"68","author":"Elias","year":"2003","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QCO.0000000000000157","article-title":"Molecular mechanisms of myocarditis caused by Trypanosoma cruzi","volume":"28","author":"Esper","year":"2015","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0042|cit42","unstructured":"Fermi Paradox crystalinks.com\/fermiparadox.html"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM197809282991304","article-title":"The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 \"negative\" trials","volume":"299","author":"Freiman","year":"1978","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD009077.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMp1207437","article-title":"Getting the methods right - the Foundation of Patient-Centered Outcomes Research","volume":"367","author":"Gabriel","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1157\/13100280","article-title":"Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic","volume":"60","author":"Gasc\u00f3n","year":"2007","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"issue":"1-2","key":"10.1002\/14651858.CD009077.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.actatropica.2009.07.019","article-title":"Chagas disease in Spain, the United States and other non-endemic countries","volume":"115","author":"Gascon","year":"2010","journal-title":"Acta Tropica"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0047|cit47","first-page":"89","article-title":"Trypanosoma cruzi-induced molecular mimicry and Chagas' disease","volume":"296","author":"Giron\u00e8s","year":"2005","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1381.046","article-title":"Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology","volume":"1107","author":"Giron\u00e8s","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10.1002\/14651858.CD009077.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/eurjhf\/hfp142","article-title":"Adherence to medication according to sex and age in the CHARM programme","volume":"11","author":"Granger","year":"2009","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/epirev\/24.1.4","article-title":"Design of randomized trials","volume":"24","author":"Green","year":"2002","journal-title":"Epidemiologic Reviews"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"705326","DOI":"10.1155\/2012\/705326","article-title":"Geographic distribution of Chagas disease vectors in Brazil based on ecological niche modelling","volume":"2012","author":"Gurgel-Goncalves","year":"2012","journal-title":"Journal of Tropical Medicine"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD009077.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009077.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009077.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009077.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009077.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00129784-200707040-00002","article-title":"Pharmacologic therapy of chronic heart failure","volume":"7","author":"Hamad","year":"2007","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"7414","key":"10.1002\/14651858.CD009077.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0063|cit63","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0008-6363(03)00361-4","article-title":"Pathophysiology of the heart in Chagas\u2019 disease: current status and new developments","volume":"60","author":"Higuchi","year":"2003","journal-title":"Cardiovascular Research"},{"issue":"10","key":"10.1002\/14651858.CD009077.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.seminhematol.2008.04.010","article-title":"Perfect study, poor evidence: interpretation of biases preceding study design","volume":"45","author":"Ioannidis","year":"2008","journal-title":"Seminars in Hematology"},{"issue":"5","key":"10.1002\/14651858.CD009077.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"9","author":"Ioannidis","year":"2008","journal-title":"Epidemiology"},{"issue":"3-4","key":"10.1002\/14651858.CD009077.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: the art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ijcard.2012.11.065","article-title":"Worldwide risk factors for heart failure: A systematic review and pooled analysis","volume":"168","author":"Khatibzadeh","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/j.1326-5377.2002.tb04759.x","article-title":"Determining the sample size in a clinical trial","volume":"177","author":"Kirby","year":"2002","journal-title":"The Medical Journal of Australia"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0071|cit71","first-page":"567","article-title":"Chagas' disease and other cardiomyopathies","volume-title":"Epidemiology and Prevention of Cardiovascular Diseases: A Global Challenge","author":"Labathe","year":"1998"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0073|cit73","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/CRD.0b013e31823efde2","article-title":"Chagas heart disease report on recent developments","volume":"20","author":"Machado","year":"2012","journal-title":"Cardiology in Review"},{"issue":"9","key":"10.1002\/14651858.CD009077.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/clc.22421","article-title":"The epidemiology, clinical manifestations, and management of Chagas heart disease","volume":"38","author":"Malik","year":"2015","journal-title":"Clinical Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD009077.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1251.e7","DOI":"10.1016\/j.amjmed.2015.04.036","article-title":"Chagas Heart Disease: An update","volume":"128","author":"Malik","year":"2015","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-5273(98)00132-6","article-title":"Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas disease","volume":"65","author":"Marin-Neto","year":"1998","journal-title":"International Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD009077.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"Marin-Neto","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0079|cit79","first-page":"257-62, 281-6","article-title":"Role of autoantibodies in the physiopathology of Chagas' disease","volume":"91","author":"Medei","year":"2008","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nurpra.2014.08.010","article-title":"Heart failure in Hispanic Americans: Improving cultural awareness","volume":"11","author":"Melton","year":"2015","journal-title":"The Journal for Nurse Practitioners"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0167-5273(01)00497-1","article-title":"The epidemiological features of heart failure in developing countries: a review of the literature","volume":"80","author":"Mendez","year":"2001","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00129784-200101020-00005","article-title":"Drug treatment of patients with decompensated heart failure","volume":"1","author":"Mills","year":"2001","journal-title":"American Journal of Cardiovascular Drugs"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD009077.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1179\/136485906X112248","article-title":"An update on Chagas disease (human American trypanosomiasis)","volume":"100","author":"Moncayo","year":"2006","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009077.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0074-02762009000900005","article-title":"Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy","volume":"104","author":"Moncayo","year":"2009","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"issue":"1-2","key":"10.1002\/14651858.CD009077.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2009.10.022","article-title":"Carlos Chagas: biographical sketch","volume":"115","author":"Moncayo","year":"2010","journal-title":"Acta Tropica"},{"issue":"12","key":"10.1002\/14651858.CD009077.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1086\/599223","article-title":"Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain","volume":"48","author":"Mu\u00f1oz","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD009077.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009077.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijantimicag.2010.03.006","article-title":"A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease","volume":"36","author":"Olivieri","year":"2010","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0091|cit91","unstructured":"Jannin J Salvatella R Quantitative estimation of Chagas Disease in the Americas Organizaci\u00f3n Panamericana de la Salud. http:\/\/ops-uruguay.bvsalud.org"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0092|cit92","unstructured":"Pietri G Van Ganse E Ferrer M Garin O Wiklund I MLHF. Minnesota living with heart failure questionnaire. User manual 178.23.156.107:8085\/Instruments_files\/USERS\/mlhf.pdf"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0093|cit93","volume-title":"A Dictionary of Epidemiology","author":"Porta","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2006.03.004","article-title":"Clinical aspects of the Chagas' heart disease","volume":"115","author":"Punukollu","year":"2007","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6215-7-21","article-title":"CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]","volume":"7","author":"Quiros","year":"2006","journal-title":"Trials"},{"issue":"9","key":"10.1002\/14651858.CD009077.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/CIRCULATIONAHA.106.627265","article-title":"Predictors of mortality in chronic Chagas disease: a systematic review of observational studies","volume":"115","author":"Rassi","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1002\/14651858.CD009077.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa053241","article-title":"Development and validation of a risk score for predicting death in Chagas' heart disease","volume":"355","author":"Rassi","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009077.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S0074-02762009000900021","article-title":"Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification","volume":"104","author":"Rassi Jr","year":"2009","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"issue":"9723","key":"10.1002\/14651858.CD009077.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0100|cit100","unstructured":"The Nordic Cochrane Centre: The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD009077.pub3-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004102.pub2","article-title":"Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)","author":"Reyes","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009077.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.molimm.2008.10.034","article-title":"Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity","volume":"46","author":"Ribeiro","year":"2009","journal-title":"Molecular Immunology"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0103|cit103","doi-asserted-by":"crossref","unstructured":"Ribeiro Machado MP Dias da Silva VJ Autonomic neuroimmunomodulation in chagasic cardiomyopathy Experimental Physiology 2012 1151 60","DOI":"10.1113\/expphysiol.2012.066381"},{"issue":"10","key":"10.1002\/14651858.CD009077.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrcardio.2012.109","article-title":"Diagnosis and management of Chagas disease and cardiomyopathy","volume":"9","author":"Ribeiro","year":"2012","journal-title":"Nature Reviews Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0167-5273(91)90012-E","article-title":"The pattern of myocardial fibrosis in chronic Chagas' heart disease","volume":"30","author":"Rossi","year":"1991","journal-title":"International Journal of Cardiology"},{"issue":"1-2","key":"10.1002\/14651858.CD009077.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: a Latin American health problem becoming a world health problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Tropica"},{"issue":"5","key":"10.1002\/14651858.CD009077.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD009077.pub3-BIB0108|cit108","first-page":"358","article-title":"Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy?","volume":"91","author":"Silva","year":"2008","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.actatropica.2009.07.014","article-title":"Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain)","volume":"112","author":"Soriano Arandes","year":"2009","journal-title":"Acta Tropica"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1590\/0037-8682-0244-2014","article-title":"Health-related quality of life in patients with Chagas disease: a review of the evidence","volume":"48","author":"Sousa","year":"2015","journal-title":"Revista Da Sociedade Brasileira De Medicina Tropical"},{"issue":"1","key":"10.1002\/14651858.CD009077.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00392-013-0613-y","article-title":"Epidemiology of Chagas disease in Europe: many calculations, little knowledge","volume":"103","author":"Strasen","year":"2014","journal-title":"Clinical Research in Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD009077.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pcad.2009.02.001","article-title":"Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease)","volume":"51","author":"Tanowitz","year":"2009","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD009077.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/CMR.00063-10","article-title":"Pathogenesis of Chagas' disease: Parasite persistence and autoimmunity","volume":"24","author":"Teixeira","year":"2011","journal-title":"Clinical Microbiology Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009077.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PloS one"},{"issue":"5","key":"10.1002\/14651858.CD009077.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/CIRCHEARTFAILURE.115.002229","article-title":"Prevalence and impact of Chagas disease among Latin American immigrants with nonischemic cardiomyopathy in Los Angeles, California","volume":"8","author":"Traina","year":"2015","journal-title":"Circulation-Heart Failure"},{"issue":"11","key":"10.1002\/14651858.CD009077.pub3-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000030.pub2","article-title":"Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals","author":"Turner","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1-2","key":"10.1002\/14651858.CD009077.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Tropica"},{"issue":"1","key":"10.1002\/14651858.CD009077.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2014.04.012","article-title":"Incidence of sudden cardiac death in congestive heart failure: Chagas disease versus systemic arterial hypertension","volume":"175","author":"Veloso","year":"2014","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD009077.pub3-BIB0119|cit119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003463","article-title":"Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection","author":"Villar","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009077.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD009077.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0065-308X(05)61004-4","article-title":"Control of Chagas disease","volume":"61","author":"Yamagata","year":"2006","journal-title":"Advances in Parasitology"},{"issue":"2","key":"10.1002\/14651858.CD009077.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1086\/314889","article-title":"Parasite persistence correlates with disease severity and localization in chronic Chagas' disease","volume":"180","author":"Zhang","year":"1999","journal-title":"The Journal of Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD009077.pub3-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009077.pub2","article-title":"Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy","author":"Hidalgo","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009077.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T16:34:45Z","timestamp":1636043685000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009077.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":123,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009077.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]}}}